{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T20:26:32Z","timestamp":1784751992948,"version":"3.55.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"40","license":[{"start":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T00:00:00Z","timestamp":1665100800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10,7]]},"abstract":"<jats:p>To investigate the predictive value of neuron-specific enolase (NSE) on intensive care unit (ICU) mortality in patients with septic shock.<\/jats:p>\n          <jats:p>Seventy-five patients with septic shock hospitalized in the emergency intensive care unit (EICU) of Hebei General Hospital from March 2020 to September 2021 were included, and the patients\u2019 baseline characteristics and laboratory findings were collected. NSE levels on the first and fourth days after admission were retrieved. NSE% [(NSEday1 \u2013 NSEday4)\/NSEday1\u2005\u00d7\u2005100%] and \u03b4NSE (NSEday1 \u2013 NSEday4) were calculated. The outcome indicator was ICU mortality. The patients were divided into the survivors group (n\u2005=\u200557) and the nonsurvivors group (n\u2005=\u200518). Multivariate analysis was performed to assess the relationship between NSE and ICU mortality. The predictive value of NSE was evaluated using receiver operating characteristic (ROC) curve.<\/jats:p>\n          <jats:p>There were no significant differences in age, gender, systolic blood pressure (SBP), heart rate (HR), acute physiology and chronic health evaluation II score (APACHE II score), source of infection, and comorbidities between the 2 groups (all <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&gt;\u2005.05). Interleukin-6 (IL-6), NSE (day1), and NSE (day4) were significantly higher in patients in the nonsurvivors group (all <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05), and there were no statistical differences in other laboratory tests between the 2 groups (all <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&gt;\u2005.05). APACHE II score, IL-6, lactate (Lac), total bilirubin (TBil), NSE (day1), and NSE (day4) showed a weak positive correlation with ICU mortality in patients with septic shock (all <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05). Multivariate logistic regression analysis demonstrated that APACHE II score (odds ratio [OR]\u2005=\u20051.166, 95% confidence interval [95% confidence interval [CI]] 1.005\u20131.352, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.042), IL-6 (OR\u2005=\u20051.001, 95% CI 1.000\u20131.001, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.003) and NSE (day4) (OR\u2005=\u20051.099, 95% CI 1.027\u20131.176, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.006) were independently associated with the ICU mortality of sepsis shock patients. The area under the curve (AUCs) of APACHE II score, IL-6, NSE (day1), and NSE (day4) for predicting prognosis were 0.650, 0.694, 0.758 and 0.770, respectively (all <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05). NSE(day4) displayed good sensitivity and specificity (Sn\u2005=\u200561.11%, Sp\u2005=\u200591.23%) for predicting ICU mortality with a cutoff value of 25.94 ug\/L.<\/jats:p>\n          <jats:p>High-level NSE (day4) is an independent predictor of ICU mortality in sepsis shock patients, which may become a good alternate option for evaluating sepsis severity. More extensive studies are needed in the future to demonstrate the prognosis value of NSE.<\/jats:p>","DOI":"10.1097\/md.0000000000030941","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T14:56:11Z","timestamp":1665413771000},"page":"e30941","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["The value of NSE to predict ICU mortality in patients with septic shock: A prospective observational study"],"prefix":"10.1097","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2020-0678","authenticated-orcid":false,"given":"Li-Tao","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Emergency, Hebei General Hospital, Shijiazhuang Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Emergency, Hebei General Hospital, Shijiazhuang Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Emergency, Hebei General Hospital, Shijiazhuang Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Min","family":"Cao","sequence":"additional","affiliation":[{"name":"Graduate School of Hebei Medical University, Shijiazhuang Hebei, China"},{"name":"Department of Oncology, Hebei General Hospital, Shijiazhuang Hebei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Ling","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Emergency, Hebei General Hospital, Shijiazhuang Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Emergency, Hebei General Hospital, Shijiazhuang Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ru","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Emergency, Hebei General Hospital, Shijiazhuang Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Guo","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Emergency, Hebei General Hospital, Shijiazhuang Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s00134-003-1662-x","article-title":"2001 SCCM\/ESICM\/ACCP\/ATS\/SIS international sepsis definitions conference.","volume":"29","author":"Levy","year":"2003","journal-title":"Intensive Care Med"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1089\/sur.2017.298","article-title":"Multiple organ dysfunction: the defining syndrome of sepsis.","volume":"19","author":"Ziesmann","year":"2018","journal-title":"Surg Infect (Larchmt)"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.niox.2013.05.001","article-title":"Contribution of iNOS\/sGC\/PKG pathway, COX-2, CYP4A1, and gp91(phox) to the protective effect of 5,14-HEDGE, a 20-HETE mimetic, against vasodilation, hypotension, tachycardia, and inflammation in a rat model of septic shock.","volume":"33","author":"Tunctan","year":"2013","journal-title":"Nitric Oxide"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00134-006-0142-5","article-title":"Septic shock: a heart story since the 1960s.","volume":"32","author":"Rabuel","year":"2006","journal-title":"Intensive Care Med"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa050333","article-title":"Incidence and outcomes of acute lung injury.","volume":"353","author":"Rubenfeld","year":"2005","journal-title":"N Engl J Med"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12974-020-1701-3","article-title":"Sepsis-associated encephalopathy: a vicious cycle of immunosuppression.","volume":"17","author":"Ren","year":"2020","journal-title":"J Neuroinflammation"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1001\/jama.1996.03530300054040","article-title":"The spectrum of septic encephalopathy. Definitions, etiologies, and mortalities.","volume":"275","author":"Eidelman","year":"1996","journal-title":"JAMA"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nrneurol.2012.183","article-title":"Sepsis-associated encephalopathy.","volume":"8","author":"Gofton","year":"2012","journal-title":"Nat Rev Neurol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1097\/CCM.0000000000002335","article-title":"Neuron-specific enolase predicts poor outcome after cardiac arrest and targeted temperature management: a multicenter study on 1,053 patients.","volume":"45","author":"Streitberger","year":"2017","journal-title":"Crit Care Med"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0003-4975(99)01393-4","article-title":"Neuron-specific enolase increases in plasma during and immediately after extracorporeal circulation.","volume":"69","author":"Johnsson","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-94-017-7215-0_9","article-title":"Neuron-specific enolase as a biomarker: biochemical and clinical aspects.","volume":"867","author":"Isgr\u00f2","year":"2015","journal-title":"Adv Exp Med Biol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3109\/02699052.2014.989403","article-title":"Association of ICP, CPP, CT findings and S-100B and NSE in severe traumatic head injury. Prognostic value of the biomarkers.","volume":"29","author":"Olivecrona","year":"2015","journal-title":"Brain Inj"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1097\/01.CCM.0000217218.51381.49","article-title":"Elevated serum levels of S-100beta protein and neuron-specific enolase are associated with brain injury in patients with severe sepsis and septic shock.","volume":"34","author":"Nguyen","year":"2006","journal-title":"Crit Care Med"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s11064-014-1308-0","article-title":"Serum S100\u03b2 is a better biomarker than neuron-specific enolase for sepsis-associated encephalopathy and determining its prognosis: a prospective and observational study.","volume":"39","author":"Yao","year":"2014","journal-title":"Neurochem Res"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3).","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/CCM.0000000000002255","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016.","volume":"45","author":"Rhodes","year":"2017","journal-title":"Crit Care Med"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1590\/1516-4446-2013-1233","article-title":"Septic encephalopathy: does inflammation drive the brain crazy?","volume":"36","author":"Dal-Pizzol","year":"2014","journal-title":"Braz J Psychiatry"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"720","DOI":"10.2174\/18715273113126660178","article-title":"Role of microglia in the pathogenesis of sepsis-associated encephalopathy.","volume":"12","author":"Deng","year":"2013","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13054-017-1643-z","article-title":"Neuroanatomy of sepsis-associated encephalopathy.","volume":"21","author":"Heming","year":"2017","journal-title":"Crit Care"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11064-019-02743-2","article-title":"Astroglia in sepsis associated encephalopathy.","volume":"45","author":"Shulyatnikova","year":"2020","journal-title":"Neurochem Res"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"600421","DOI":"10.3389\/fphar.2020.600421","article-title":"Microglia: a potential therapeutic target for sepsis-associated encephalopathy and sepsis-associated chronic pain.","volume":"11","author":"Li","year":"2020","journal-title":"Front Pharmacol"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/2110-5820-3-15","article-title":"Understanding brain dysfunction in sepsis.","volume":"3","author":"Sonneville","year":"2013","journal-title":"Ann Intensive Care"},{"key":"R24-20250504","first-page":"747","article-title":"The diagnostic value of neuron-specific enolase, central nervous system specific protein and interleukin-6 in sepsis-associated encephalopathy.","volume":"56","author":"Feng","year":"2017","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"e0211184","DOI":"10.1371\/journal.pone.0211184","article-title":"The prognostic value of neurofilament levels in patients with sepsis-associated encephalopathy \u2013 a prospective, pilot observational study.","volume":"14","author":"Ehler","year":"2019","journal-title":"PLoS One"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"907","DOI":"10.14740\/jocmr3083w","article-title":"Predicting mortality of patients with sepsis: a comparison of APACHE II and APACHE III scoring systems.","volume":"9","author":"Sadaka","year":"2017","journal-title":"J Clin Med Res"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2147\/JIR.S348490","article-title":"Establishment and effectiveness evaluation of a scoring system-RAAS (RDW, AGE, APACHE II, SOFA) for sepsis by a retrospective analysis.","volume":"15","author":"Huang","year":"2022","journal-title":"J Inflamm Res"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.ajog.2006.01.073","article-title":"Utility of acute physiology, age, and chronic health evaluation (APACHE III) score in maternal admissions to the intensive care unit.","volume":"194","author":"Stevens","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ymeth.2013.04.024","article-title":"Is there value in plasma cytokine measurements in patients with severe trauma and sepsis?","volume":"61","author":"Gentile","year":"2013","journal-title":"Methods"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1515\/jccm-2017-0001","article-title":"The relevance of coding gene polymorphysms of cytokines and cellular receptors in sepsis.","volume":"3","author":"Georgescu","year":"2017","journal-title":"J Crit Care Med (Targu Mures)"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1515\/cclm-2018-0259","article-title":"Procalcitonin-guided antibiotic therapy: an expert consensus.","volume":"56","author":"Bartoletti","year":"2018","journal-title":"Clin Chem Lab Med"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/CCM.0000000000002321","article-title":"Serial procalcitonin predicts mortality in severe sepsis patients: results from the multicenter procalcitonin MOnitoring SEpsis (MOSES) study.","volume":"45","author":"Schuetz","year":"2017","journal-title":"Crit Care Med"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"732410","DOI":"10.3389\/fmed.2021.732410","article-title":"Clinical value of the lactate\/albumin ratio and lactate\/albumin ratio \u00d7 age score in the assessment of prognosis in patients with sepsis.","volume":"8","author":"Chen","year":"2021","journal-title":"Front Med (Lausanne)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030941","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:39:47Z","timestamp":1746333587000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,7]]},"references-count":32,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000030941","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,7]]}}}